Benign neoplasm of prostate (disorder)
PROVENT (Feasibility)
Year Started: 2016
A randomised, double blind, placebo controlled feasibility study to examine the clinical effectiveness of aspirin and/or Vitamin D3 to prevent disease progression in men on Active Surveillance for prostate cancer
- Access:
- Access restricted at present
- Type:
- Clinical Trial
- Status:
- In progress
- Consent restrictions:
- No restrictions
Associated Data Type | Procurement Timeframe |
---|---|
Biomarker datasets | > 6 months |
Freezer temperature logs | Immediate |
Genomic datasets | > 6 months |
Male
Adult (> 40 years)
101 - 500 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Serum | -60°C to -85°C | N/A | Affected | 0 - 10% | |
Tissue specimen | Surgical procedure (procedure) | RT | Paraffin | Non-affected | 0 - 10% |
Urine | -60°C to -85°C | N/A | Non-affected | 0 - 10% | |
Whole blood | -60°C to -85°C | N/A | Affected | 0 - 10% |